AAAAAA

   
Results: 1-9 |
Results: 9
INVOLVEMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR PAI-1 IN IN-VITRO GROWTH OF HUMAN BREAST-CANCER CELL-LINES
Authors: PRIFTI S FERSIS N SILLEM M SZEKELYI M RUNNEBAUM B BASTERT G
Citation: S. Prifti et al., INVOLVEMENT OF PLASMINOGEN-ACTIVATOR INHIBITOR PAI-1 IN IN-VITRO GROWTH OF HUMAN BREAST-CANCER CELL-LINES, European journal of cancer, 34, 1998, pp. 13-13
PROGNOSTIC VALUE OF PLASMINOGENAKTIVATOR INHIBITOR TYPE-1 AND TYPE-2 IN PRIMARY BREAST-CANCER
Authors: FERSIS N KRAINICK U FRISE H THRON S SZEKELYI M WITTMANN G WALLWIENER D BASTERT G
Citation: N. Fersis et al., PROGNOSTIC VALUE OF PLASMINOGENAKTIVATOR INHIBITOR TYPE-1 AND TYPE-2 IN PRIMARY BREAST-CANCER, European journal of cancer, 34, 1998, pp. 39-39
EFFICACY AND TOXICITY OF SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK BREAST-CANCER
Authors: HOHAUS S WALLWIENER D MARTIN S VOSO MT HUOBER J FERSIS N BASTERT G HAAS R
Citation: S. Hohaus et al., EFFICACY AND TOXICITY OF SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT IN PATIENTS WITH HIGH-RISK BREAST-CANCER, Seminars in oncology, 25(2), 1998, pp. 7-11
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: FERSIS N HAAS R WALLWIENER D HOHAUS S FRUHAUF S BASTERT G
Citation: N. Fersis et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER, Breast, 6(5), 1997, pp. 321-321
HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC)
Authors: HUOBER J WALLWIENER D FERSIS N BASTERT G
Citation: J. Huober et al., HIGH-DOSE CHEMOTHERAPY (HDC) AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL SUPPORT (PBSC) IN PATIENTS WITH METASTATIC BREAST-CANCER (MBC), European journal of cancer, 33, 1997, pp. 415-415
HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER
Authors: FERSIS N HAAS R WALLWIENER D HOHAUS S HUOBER J BASTERT G
Citation: N. Fersis et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT (PBPC) FOR THE TREATMENT OF ADVANCED BREAST-CANCER, European journal of cancer, 33, 1997, pp. 661-661
INHIBITION OF 5-ALPHA-REDUCTASE ACTIVITY IN HUMAN SKIN BY SYNTHETIC STEROID-HORMONES
Authors: FELDMANN K REHBERGER S GRUNWALD K RABE T FERSIS N RUNNEBAUM B
Citation: K. Feldmann et al., INHIBITION OF 5-ALPHA-REDUCTASE ACTIVITY IN HUMAN SKIN BY SYNTHETIC STEROID-HORMONES, Human reproduction, 12, 1997, pp. 212-212
TANDEM HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN 105 PATIENTS WITH HIGH-RISK BREAST-CANCER
Authors: HOHAUS S MARTIN S SCHNEEWEISS A HUOBER J FERSIS N GOLDSCHMIDT H WALLWIENER D BASTERT G HAAS R
Citation: S. Hohaus et al., TANDEM HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN 105 PATIENTS WITH HIGH-RISK BREAST-CANCER, Blood, 90(10), 1997, pp. 4560-4560
PROGNOSTIC IMPORTANCE OF PLASMINOGEN INHI BITOR-1 (PAI-1) IN PRIMARY BREAST-CANCER
Authors: FERSIS N KAUFFMANN M KRAMER MD WITTMANN G WALLWIENER D BASTERT G
Citation: N. Fersis et al., PROGNOSTIC IMPORTANCE OF PLASMINOGEN INHI BITOR-1 (PAI-1) IN PRIMARY BREAST-CANCER, Geburtshilfe und Frauenheilkunde, 56(1), 1996, pp. 28-34
Risultati: 1-9 |